Tower Research Capital LLC (TRC) - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 3 filers reported holding REGENXBIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of REGENXBIO INC
ValueSharesWeighting
Q3 2023$76,342
+142.9%
4,638
+195.0%
0.00%
+100.0%
Q2 2023$31,424
+104646.7%
1,572
-0.6%
0.00%0.0%
Q1 2023$30
-79.3%
1,582
-75.3%
0.00%
-83.3%
Q4 2022$145
-99.9%
6,392
+6.9%
0.01%
+100.0%
Q3 2022$158,000
+9.0%
5,980
+2.0%
0.00%0.0%
Q2 2022$145,000
-45.1%
5,863
-26.1%
0.00%0.0%
Q1 2022$264,000
+11.4%
7,939
+9.5%
0.00%
-25.0%
Q4 2021$237,000
-26.2%
7,251
-5.5%
0.00%
-50.0%
Q3 2021$321,000
+184.1%
7,674
+162.0%
0.01%
+166.7%
Q2 2021$113,000
+21.5%
2,929
+6.7%
0.00%
+50.0%
Q1 2021$93,000
+22.4%
2,745
+64.9%
0.00%0.0%
Q4 2020$76,000
+55.1%
1,665
-7.1%
0.00%
+100.0%
Q3 2020$49,000
-78.9%
1,793
-71.6%
0.00%
-90.0%
Q2 2020$232,000
+110.9%
6,305
+85.4%
0.01%
+42.9%
Q1 2020$110,000
+11.1%
3,401
+40.2%
0.01%
-12.5%
Q4 2019$99,000
+2375.0%
2,425
+3221.9%
0.01%
Q1 2019$4,000
-80.0%
73
-73.1%
0.00%
-100.0%
Q3 2018$20,000
-13.0%
271
-64.2%
0.00%
-50.0%
Q1 2018$23,000
+27.8%
756
+37.5%
0.00%0.0%
Q4 2017$18,000
-37.9%
550
-37.7%
0.00%0.0%
Q3 2017$29,000
+1350.0%
883
+819.8%
0.00%
Q2 2017$2,000
-97.8%
96
-97.9%
0.00%
-100.0%
Q1 2017$90,000
+8900.0%
4,644
+6350.0%
0.01%
Q4 2016$1,000
-96.4%
72
-97.9%
0.00%
-100.0%
Q2 2016$28,0003,430
+85650.0%
0.00%
Q1 2016$0
-100.0%
4
-99.6%
0.00%
-100.0%
Q4 2015$17,000
-19.0%
995
+5.9%
0.00%
+50.0%
Q3 2015$21,0009400.00%
Other shareholders
REGENXBIO INC shareholders Q4 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 839,139$35,177,0006.39%
Sonic Fund II, L.P. 188,786$7,914,0004.47%
ArchPoint Investors 297,355$12,465,0003.73%
Redmile Group, LLC 2,008,001$84,175,0001.47%
RTW INVESTMENTS, LP 1,845,366$77,358,0001.17%
WS MANAGEMENT LLLP 210,729$8,834,0000.94%
FRAZIER MANAGEMENT LLC 235,809$9,885,0000.79%
Integral Health Asset Management, LLC 55,000$2,306,0000.66%
Sofinnova Investments, Inc. 127,593$5,349,0000.32%
HHLR ADVISORS, LTD. 456,000$19,116,0000.25%
View complete list of REGENXBIO INC shareholders